162 related articles for article (PubMed ID: 34520958)
1. Peptidylarginine deiminases 4 as a promising target in drug discovery.
Yang C; Dong ZZ; Zhang J; Teng D; Luo X; Li D; Zhou Y
Eur J Med Chem; 2021 Dec; 226():113840. PubMed ID: 34520958
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new inhibitor for the protein arginine deiminase type 4 (PAD4) by rational design of α-enolase-derived peptides.
Ahmad Nadzirin I; Chor ALT; Salleh AB; Rahman MBA; Tejo BA
Comput Biol Chem; 2021 Jun; 92():107487. PubMed ID: 33957477
[TBL] [Abstract][Full Text] [Related]
3. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.
Teo CY; Shave S; Chor AL; Salleh AB; Rahman MB; Walkinshaw MD; Tejo BA
BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S4. PubMed ID: 23282142
[TBL] [Abstract][Full Text] [Related]
5. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
Wang Y; Chen R; Gan Y; Ying S
Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.
Du M; Yang W; Schmull S; Gu J; Xue S
Int Immunopharmacol; 2020 Jan; 78():106055. PubMed ID: 31816575
[TBL] [Abstract][Full Text] [Related]
7. PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease.
Liu X; Arfman T; Wichapong K; Reutelingsperger CPM; Voorberg J; Nicolaes GAF
J Thromb Haemost; 2021 Jul; 19(7):1607-1617. PubMed ID: 33773016
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis.
Thirugnanasambandham I; Radhakrishnan A; Kuppusamy G; Kumar Singh S; Dua K
Biochem Pharmacol; 2022 Jun; 200():115040. PubMed ID: 35436466
[TBL] [Abstract][Full Text] [Related]
9. Viral mimetic poly(I:C) induces neutrophil extracellular traps via PAD4 to promote inflammation and thrombosis.
Ai P; Pan H; Chen K; Zheng J; Gao Z; Jin G
Biochem Biophys Res Commun; 2021 Aug; 565():64-71. PubMed ID: 34098313
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.
Shen Y; You Q; Wu Y; Wu J
Eur J Pharmacol; 2022 Feb; 916():174623. PubMed ID: 34767782
[TBL] [Abstract][Full Text] [Related]
12. Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4.
Gajendran C; Fukui S; Sadhu NM; Zainuddin M; Rajagopal S; Gosu R; Gutch S; Fukui S; Sheehy CE; Chu L; Vishwakarma S; Jeyaraj DA; Hallur G; Wagner DD; Sivanandhan D
Sci Rep; 2023 Feb; 13(1):3189. PubMed ID: 36823444
[TBL] [Abstract][Full Text] [Related]
13. The role of protein arginine deiminase 4-dependent neutrophil extracellular traps formation in ulcerative colitis.
Wang P; Liu D; Zhou Z; Liu F; Shen Y; You Q; Lu S; Wu J
Front Immunol; 2023; 14():1144976. PubMed ID: 37143672
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
15. Screening of natural inhibitors against peptidyl arginine deiminase 4 from herbal extracts by a high-performance liquid chromatography ultraviolet-visible based method.
Zhao J; Li Y; Gao C; Zhao Z; Zhang S; Dong J; Zuo H; Chen X; Xie B; Guo Z; Wang Y; Li H; Bian Y
J Chromatogr A; 2024 Feb; 1716():464643. PubMed ID: 38232639
[TBL] [Abstract][Full Text] [Related]
16. A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.
Li M; Lin C; Deng H; Strnad J; Bernabei L; Vogl DT; Burke JJ; Nefedova Y
Mol Cancer Ther; 2020 Jul; 19(7):1530-1538. PubMed ID: 32371579
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity.
Molinaro R; Yu M; Sausen G; Bichsel CA; Corbo C; Folco EJ; Lee GY; Liu Y; Tesmenitsky Y; Shvartz E; Sukhova GK; Kloss F; Croce KJ; Farokhzad OC; Shi J; Libby P
Cardiovasc Res; 2021 Nov; 117(13):2652-2663. PubMed ID: 33751034
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury.
Raup-Konsavage WM; Wang Y; Wang WW; Feliers D; Ruan H; Reeves WB
Kidney Int; 2018 Feb; 93(2):365-374. PubMed ID: 29061334
[TBL] [Abstract][Full Text] [Related]
19. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation.
Wang Y; Li M; Stadler S; Correll S; Li P; Wang D; Hayama R; Leonelli L; Han H; Grigoryev SA; Allis CD; Coonrod SA
J Cell Biol; 2009 Jan; 184(2):205-13. PubMed ID: 19153223
[TBL] [Abstract][Full Text] [Related]
20. Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression.
Li P; Wang D; Yao H; Doret P; Hao G; Shen Q; Qiu H; Zhang X; Wang Y; Chen G; Wang Y
Oncogene; 2010 May; 29(21):3153-62. PubMed ID: 20190809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
